ClinicalTrials.Veeva

Menu

Compliance With Once Daily Glaucoma Medication

Alcon logo

Alcon

Status

Completed

Conditions

Compliance

Treatments

Behavioral: Intervention

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT00333463
CMS-06-03

Details and patient eligibility

About

A study to examine patient compliance with once daily glaucoma medication

Enrollment

700 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Primary open angle glaucoma or ocular hypertension patients

Exclusion criteria

  • None

Trial design

700 participants in 2 patient groups

Intervention group
Description:
The intervention group watched an educational video, reviewed current barriers to drop-taking and possible solutions with a study coordinator, received regular phone call reminders, and had audible and visible reminders activated on their DA devices.
Treatment:
Behavioral: Intervention
Non-Intervention Group
Description:
The control group was told to take drops as prescribed and received no additional intervention.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems